2008 DOSE-RANGING, THREE-DAY MONOTHERAPY STUDY OF THE HCV NS3 PROTEASE INHIBITOR GS-9256

Autor: Lawitz, E.J., Marbury, T.C., Vince, B.D., Grunenberg, N., Rodriguez-Torres, M., De Micco, M.P., Tarro, J.N., Shelton, M.J., West, S., Zong, J., Bae, A., Wong, K., Mo, H.-M., Oldach, D., Delaney, W., Rousseau, F.
Zdroj: In Journal of Hepatology 2010 52 Supplement 1:S466-S467
Databáze: ScienceDirect